• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤相关巨噬细胞作为肿瘤微环境中的主要免疫抑制细胞

Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment.

作者信息

Ghebremedhin Anghesom, Athavale Dipti, Zhang Yanting, Yao Xiaodan, Balch Curt, Song Shumei

机构信息

Coriell Institute for Medical Research, 403 Haddon Ave., Camden, NJ 08103, USA.

Department Biomedical Sciences, Cooper Medical School of Rowan University, 401 Broadway, Camden, NJ 08103, USA.

出版信息

Cancers (Basel). 2024 Oct 8;16(19):3410. doi: 10.3390/cancers16193410.

DOI:10.3390/cancers16193410
PMID:39410029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11475569/
Abstract

Within the tumor microenvironment, myeloid cells constitute a dynamic immune population characterized by a heterogeneous phenotype and diverse functional activities. In this review, we consider recent literature shedding light on the increasingly complex biology of M2-like immunosuppressive tumor-associated macrophages (TAMs), including their contribution to tumor cell invasion and metastasis, stromal remodeling (fibrosis and matrix degradation), and immune suppressive functions, in the tumor microenvironment (TME). This review also delves into the intricate signaling mechanisms underlying the polarization of diverse macrophage phenotypes, and their plasticity. We also review the development of promising therapeutic approaches to target these populations in cancers. The expanding knowledge of distinct subsets of immunosuppressive TAMs, and their contributions to tumorigenesis and metastasis, has sparked significant interest among researchers regarding the therapeutic potential of TAM depletion or phenotypic modulation.

摘要

在肿瘤微环境中,髓系细胞构成了一个动态的免疫群体,其特征是具有异质性表型和多样的功能活性。在本综述中,我们探讨了近期的文献,这些文献揭示了M2样免疫抑制性肿瘤相关巨噬细胞(TAM)日益复杂的生物学特性,包括它们在肿瘤微环境(TME)中对肿瘤细胞侵袭和转移、基质重塑(纤维化和基质降解)以及免疫抑制功能的贡献。本综述还深入研究了不同巨噬细胞表型极化背后的复杂信号机制及其可塑性。我们还回顾了针对癌症中这些细胞群体的有前景的治疗方法的进展。对免疫抑制性TAM不同亚群的不断扩展的认识,以及它们对肿瘤发生和转移的贡献,引发了研究人员对TAM耗竭或表型调节治疗潜力的浓厚兴趣。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fd/11475569/28a91ee9fab0/cancers-16-03410-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fd/11475569/c5439b115a23/cancers-16-03410-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fd/11475569/28a91ee9fab0/cancers-16-03410-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fd/11475569/c5439b115a23/cancers-16-03410-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76fd/11475569/28a91ee9fab0/cancers-16-03410-g002.jpg

相似文献

1
Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment.肿瘤相关巨噬细胞作为肿瘤微环境中的主要免疫抑制细胞
Cancers (Basel). 2024 Oct 8;16(19):3410. doi: 10.3390/cancers16193410.
2
The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development.NR_109/FUBP1/c-Myc 轴调节 TAM 极化并重塑肿瘤微环境以促进癌症发展。
J Immunother Cancer. 2023 May;11(5). doi: 10.1136/jitc-2022-006230.
3
Modulation of Tumor-Associated Macrophages to Overcome Immune Suppression in the Hepatocellular Carcinoma Microenvironment.调节肿瘤相关巨噬细胞以克服肝细胞癌微环境中的免疫抑制
Cancers (Basel). 2024 Dec 29;17(1):66. doi: 10.3390/cancers17010066.
4
Pulmonary administration of a CSF-1R inhibitor alters the balance of tumor-associated macrophages and supports first-line chemotherapy in a lung cancer model.肺部给予 CSF-1R 抑制剂可改变肿瘤相关巨噬细胞的平衡,并在肺癌模型中支持一线化疗。
Int J Pharm. 2021 Apr 1;598:120350. doi: 10.1016/j.ijpharm.2021.120350. Epub 2021 Feb 2.
5
Traditional Chinese medicine in the prevention and treatment of lung cancer metastasis by regulating tumor-associated macrophages: a narrative review.传统中医通过调节肿瘤相关巨噬细胞预防和治疗肺癌转移:一项叙述性综述
Transl Lung Cancer Res. 2025 Jun 30;14(6):2281-2295. doi: 10.21037/tlcr-2025-380. Epub 2025 Jun 26.
6
Targeting tumor-associated macrophages in gastric cancer progression and therapy: insights from molecular mechanisms to therapeutic applications.靶向肿瘤相关巨噬细胞在胃癌进展和治疗中的作用:从分子机制到治疗应用的见解
Front Pharmacol. 2025 Jun 17;16:1549694. doi: 10.3389/fphar.2025.1549694. eCollection 2025.
7
Regulation of macrophage plasticity by circCCDC719-13 through HSP90 inhibition suppresses prostate cancer progression and metastasis: a translational study.circCCDC719-13通过抑制HSP90对巨噬细胞可塑性的调控抑制前列腺癌进展和转移:一项转化研究
Int J Surg. 2025 Jun 27. doi: 10.1097/JS9.0000000000002895.
8
Functionally and Metabolically Divergent Melanoma-Associated Macrophages Originate from Common Bone-Marrow Precursors.功能和代谢上不同的黑色素瘤相关巨噬细胞起源于共同的骨髓前体。
Cancers (Basel). 2023 Jun 24;15(13):3330. doi: 10.3390/cancers15133330.
9
Tumor-associated macrophages in radiotherapy: Mechanisms of polarization, immune regulation and therapeutic strategies.放射治疗中的肿瘤相关巨噬细胞:极化机制、免疫调节及治疗策略
Int Immunopharmacol. 2025 Aug 28;161:115009. doi: 10.1016/j.intimp.2025.115009. Epub 2025 Jun 5.
10
AXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarization.AXL通过调节免疫抑制性巨噬细胞极化促进炎性乳腺癌进展。
Breast Cancer Res. 2025 May 6;27(1):70. doi: 10.1186/s13058-025-02015-8.

引用本文的文献

1
Redefining Chemoresistance: Natural Bioactives as Molecular Modulators at the Cancer-Tumor Microenvironment Interface.重新定义化疗耐药性:天然生物活性物质作为癌症-肿瘤微环境界面的分子调节剂
Int J Mol Sci. 2025 Aug 20;26(16):8037. doi: 10.3390/ijms26168037.
2
Emerging Biomimetic Drug Delivery Nanoparticles Inspired by Extracellular Vesicles.受细胞外囊泡启发的新型仿生药物递送纳米颗粒
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Jul-Aug;17(4):e70025. doi: 10.1002/wnan.70025.
3
Interplay of Neuroinflammation and Epilepsy in Glioblastoma Multiforme: Mechanisms and Therapeutic Implications.

本文引用的文献

1
Targeting conserved TIM3VISTA tumor-associated macrophages overcomes resistance to cancer immunotherapy.靶向保守的 TIM3VISTA 肿瘤相关巨噬细胞克服癌症免疫治疗耐药性。
Sci Adv. 2024 Jul 19;10(29):eadm8660. doi: 10.1126/sciadv.adm8660.
2
Targeting the Depletion of M2 Macrophages: Implication in Cancer Immunotherapy.靶向 M2 巨噬细胞耗竭:在癌症免疫治疗中的意义。
Crit Rev Oncog. 2024;29(4):55-73. doi: 10.1615/CritRevOncog.2024053580.
3
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
多形性胶质母细胞瘤中神经炎症与癫痫的相互作用:机制及治疗意义
J Mol Neurosci. 2025 May 20;75(2):68. doi: 10.1007/s12031-025-02335-6.
4
Tumor microenvironment and immune-related myositis: addressing muscle wasting in cancer immunotherapy.肿瘤微环境与免疫相关肌炎:解决癌症免疫治疗中的肌肉萎缩问题
Front Immunol. 2025 May 2;16:1580108. doi: 10.3389/fimmu.2025.1580108. eCollection 2025.
5
The Synergistic Mechanisms and Prospects of Transarterial Chemoembolization Combined with Immunotherapy for Hepatocellular Carcinoma.经动脉化疗栓塞联合免疫疗法治疗肝细胞癌的协同机制及前景
J Hepatocell Carcinoma. 2025 Apr 30;12:841-854. doi: 10.2147/JHC.S514881. eCollection 2025.
6
Targeting tumor-associated macrophages in colon cancer: mechanisms and therapeutic strategies.靶向结肠癌中的肿瘤相关巨噬细胞:机制与治疗策略
Front Immunol. 2025 Mar 21;16:1573917. doi: 10.3389/fimmu.2025.1573917. eCollection 2025.
7
Precise gene expression deconvolution in spatial transcriptomics with STged.利用STged在空间转录组学中进行精确的基因表达反卷积分析。
Nucleic Acids Res. 2025 Feb 8;53(4). doi: 10.1093/nar/gkaf087.
2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
4
Siglec9 + tumor-associated macrophages predict prognosis and therapeutic vulnerability in patients with colon cancer.唾液酸结合免疫球蛋白样凝集素9(Siglec9)阳性肿瘤相关巨噬细胞可预测结肠癌患者的预后及治疗易损性。
Int Immunopharmacol. 2024 Mar 30;130:111771. doi: 10.1016/j.intimp.2024.111771. Epub 2024 Mar 2.
5
Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance.靶向M2样肿瘤相关巨噬细胞是克服抗肿瘤耐药性的一种潜在治疗方法。
NPJ Precis Oncol. 2024 Feb 10;8(1):31. doi: 10.1038/s41698-024-00522-z.
6
Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions.靶向CD24/Siglec-10信号通路用于癌症免疫治疗:最新进展与未来方向
Cancer Immunol Immunother. 2024 Jan 27;73(2):31. doi: 10.1007/s00262-023-03606-0.
7
Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models.在人源化小鼠模型中评估针对人 SIRPα 的抗体用于癌症免疫疗法的疗效的临床前评价。
Front Immunol. 2023 Dec 14;14:1294814. doi: 10.3389/fimmu.2023.1294814. eCollection 2023.
8
Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition.靶向CD47-SIRPa轴作为单一疗法显示出强大的临床前抗肿瘤活性,并与PARP抑制协同作用。
NPJ Precis Oncol. 2023 Jul 19;7(1):69. doi: 10.1038/s41698-023-00418-4.
9
IDO1 Promotes the Progression of NSCLC by Regulating the Polarization of M2 Macrophages.吲哚胺2,3-双加氧酶1通过调节M2巨噬细胞极化促进非小细胞肺癌进展。
Int J Gen Med. 2023 May 8;16:1713-1733. doi: 10.2147/IJGM.S398908. eCollection 2023.
10
CD40 signal rewires fatty acid and glutamine metabolism for stimulating macrophage anti-tumorigenic functions.CD40 信号重塑脂肪酸和谷氨酰胺代谢以刺激巨噬细胞抗肿瘤功能。
Nat Immunol. 2023 Mar;24(3):452-462. doi: 10.1038/s41590-023-01430-3. Epub 2023 Feb 23.